PUBCHEM ID | 196 |
Molecular Weight (g/mol) | 146.146 |
Molecular Formula | C6H10O4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
IUPAC Name | Adipicacid |
Canonical SMILES | O=C(O)CCCCC(=O)O |
PUBCHEM IUPAC INCHIKEY | WNLRTRBMVRJNCN-UHFFFAOYSA-N |
Solubility Level | 5 |
Vapour Pressure | -5.886 |
XLOGP3 AA | NA |
CACTVS TPSA | 37.29 |
BBB Level | 3 |
Absorption Level | 0 |
EXT PPB#Prediction | 0 |
AlogP98 | 0.553 |
EXT CYP2D6#Prediction | 0 |
Mouse Female FDA | Non-Carcinogen |
Mouse Male FDA | Multi-Carcinogen |
Rat Female FDA | Single-Carcinogen |
Rat Male FDA | Multi-Carcinogen |
Ames Prediction | Non-Mutagen |
Developmental / Reproductive Toxicity | Non-Toxic |
Rat Oral LD50 | 3.61844 |
Ocular Irritancy | None |
Hepatotoxic#Prediction | 0 |
Effected Human Genes | NA |
Aerobic Biodegradability Prediction | Degradable |
Physical hazards | not classified |
Health hazards | None |
Environmental hazards | not classified |
Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
---|---|---|---|---|---|---|
1 | 124-04-9 | SLC22A6 | Homo sapiens | adipic acid inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]] | affects^cotreatment|decreases^reaction|increases^response to substance | 12606766 |
2 | 124-04-9 | SLC22A6 | Homo sapiens | adipic acid inhibits the reaction [SLC22A6 protein results in increased susceptibility to [mercuric oxide co-treated with Acetylcysteine]] | affects^cotreatment|decreases^reaction|increases^response to substance | 12606766 |
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|---|---|---|---|---|
1 | 124-04-9 | 1,4-Butanedicarboxylic acid |